- Home
- PRCT vs TLRY Comparison
PRCT vs TLRY Comparison
Compare PRCT & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRCT | TLRY |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PRCT | TLRY |
|---|---|---|
| Price | $32.23 | $11.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $51.13 | ★ $150.00 |
| AVG Volume (30 Days) | 1.6M | ★ 18.2M |
| Earning Date | 11-04-2025 | 01-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $299,907,000.00 | ★ $830,766,000.00 |
| Revenue This Year | $48.34 | $7.28 |
| Revenue Next Year | $29.35 | $4.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 50.07 | 2.31 |
| 52 Week Low | $27.80 | $3.51 |
| 52 Week High | $89.49 | $23.20 |
Technical Indicators
Market Signals| Indicator | PRCT | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 44.94 | 68.14 |
| Support Level | $33.27 | $10.50 |
| Resistance Level | $36.60 | $15.70 |
| Average True Range (ATR) | 1.98 | 1.49 |
| MACD | -0.10 | 0.46 |
| Stochastic Oscillator | 35.17 | 47.67 |
Price Performance
Historical ComparisonAbout PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.